Macrolide-Resistant <i>Mycoplasma pneumoniae</i> Infections among Children after COVID-19 Pandemic, Ohio, USA
Mycoplasma pneumoniae infections decreased in Ohio, USA, during the COVID-19 pandemic but reemerged in 2023; >2,000 cases were reported during September 2023--September 2024. Of 995 M. pneumoniae-positive samples, 24 (2.4%) had mutations for macrolide-resistant M. pneumoniae (MRMp). MRMp rates are low but increasing. MRMp surveillance is crucial for monitoring antimicrobial resistance.
Authors
- Amy L. Leber (ORCID: https://orcid.org/0000-0002-3075-3586)
- Jeanette Taveras
- Sophonie J. Oyeniran (ORCID: https://orcid.org/0000-0001-9372-3491)
- Kathy Everhart
- Huanyu Wang (ORCID: https://orcid.org/0000-0002-5982-6371)
- Tori Embry
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2025-02-21
- DOI
- https://doi.org/10.3201/eid3103.241570
- Citations
- 10
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 13.54